Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,277 | 121,330 | 68,789 | 67,802 | 101,121 |
| Marketable Securities | 73,837 | 26,004 | N/A | 20,196 | N/A |
| Receivables | 22,007 | 25,368 | 22,732 | 19,539 | 10,005 |
| Other current assets | 11,537 | 14,664 | 11,630 | 12,054 | 7,591 |
| TOTAL | $118,658 | $187,366 | $103,151 | $119,591 | $118,717 |
| Non-Current Assets | |||||
| PPE Net | 1,581 | 1,818 | 1,938 | 2,722 | 2,673 |
| Investments And Advances | 0 | 0 | 0 | 351 | 414 |
| Intangibles | 10,909 | 9,704 | 10,343 | 10,302 | 10,473 |
| Other Non-Current Assets | 294 | 3,747 | 4,016 | 0 | 0 |
| TOTAL | $12,784 | $15,269 | $16,297 | $13,376 | $13,560 |
| Total Assets | $131,442 | $202,635 | $119,448 | $132,967 | $132,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,356 | 16,399 | 15,537 | 15,626 | 14,828 |
| Other current liabilities | 168 | 306 | 6,571 | 10,964 | 5,840 |
| TOTAL | $13,613 | $16,822 | $22,336 | $27,141 | $20,856 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55,525 | 51,790 | 75,119 | 78,525 | 99,696 |
| TOTAL | $55,525 | $51,790 | $75,119 | $78,525 | $99,696 |
| Total Liabilities | $69,138 | $68,612 | $97,455 | $105,666 | $120,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,234 | N/A | N/A | N/A | 29,928 |
| Common Shares | 10,290 | 10,288 | 8,847 | 6,667 | 6,173 |
| Retained earnings | -562,572 | -474,044 | -431,894 | -325,630 | -306,601 |
| Other shareholders' equity | -2,976 | -11,781 | -10,725 | 2,579 | 2,119 |
| TOTAL | $62,304 | $134,023 | $21,993 | $27,301 | $11,724 |
| Total Liabilities And Equity | $131,442 | $202,635 | $119,448 | $132,967 | $132,276 |